Definition and epidemiology
Gangrene refers to tissue death that occurs when blood supply is severely compromised or when tissue becomes infected with specific bacteria. The condition represents the end stage of tissue injury and is classified into several types based on etiology and clinical presentation.
Types of gangrene:
- Dry gangrene: Ischemic necrosis without bacterial infection, typically affecting extremities
- Wet gangrene: Ischemic tissue with superimposed bacterial infection, characterized by putrefaction
- Gas gangrene: Clostridial myonecrosis with gas production in tissues
- Fournier gangrene: Necrotizing fasciitis of the perineum and genitalia
- Internal gangrene: Affects internal organs (bowel, gallbladder, appendix)
Gangrene affects approximately 1-2 per 1,000 adults annually in developed countries, with incidence increasing sharply with age. The condition is 2-3 times more common in men than women. Diabetic patients have a 15-fold higher risk of lower extremity gangrene compared to non-diabetics. Peripheral arterial disease (PAD) is present in over 90% of cases involving the limbs. Mortality ranges from 5-10% for dry gangrene to 20-40% for wet gangrene and up to 40% for gas gangrene despite treatment.
- Dry gangrene has clear demarcation and no infection; wet gangrene has bacterial infection with edema and systemic toxicity
- Gas gangrene is caused by Clostridium perfringens producing alpha toxin; treatment is immediate debridement plus penicillin and clindamycin
- Crepitus on physical examination indicates gas in tissues and suggests gas gangrene or necrotizing fasciitis
- Diabetes mellitus and peripheral arterial disease are the two most common predisposing factors for lower extremity gangrene
- Wet gangrene and gas gangrene are surgical emergencies requiring immediate debridement and broad-spectrum antibiotics
- Hyperbaric oxygen therapy is adjunctive treatment for gas gangrene but never replaces surgical debridement
- Fournier gangrene is necrotizing fasciitis of the perineum with high mortality; requires aggressive perineal debridement
- Conversion of dry to wet gangrene occurs when ischemic tissue becomes superinfected with bacteria
Etiology and risk factors
Gangrene develops when tissue perfusion falls below the threshold needed for cellular viability or when aggressive bacterial infection overwhelms tissue defenses.
Major causes:
- Peripheral arterial disease: Atherosclerotic occlusion, thromboembolism, acute arterial thrombosis
- Diabetes mellitus: Microvascular disease, neuropathy, impaired wound healing, immunosuppression
- Trauma: Crush injuries, frostbite, burns, compartment syndrome
- Infection: Clostridium perfringens (gas gangrene), polymicrobial (wet gangrene)
- Vasculitis: Polyarteritis nodosa, Buerger disease (thromboangiitis obliterans)
- Embolism: Atrial fibrillation, endocarditis, cholesterol emboli
- Venous occlusion: Deep vein thrombosis, venous gangrene (phlegmasia cerulea dolens)
- Iatrogenic: Intra-arterial injection, extravasation of vasopressors
Risk factors:
- Age >60 years
- Smoking (dose-dependent risk)
- Diabetes mellitus with poor glycemic control
- Hyperlipidemia and hypertension
- Chronic kidney disease
- Immunosuppression (HIV, chemotherapy, corticosteroids)
- Malnutrition and obesity
- Previous vascular surgery or amputation
- Intravenous drug use
Pathophysiology
Gangrene represents the culmination of irreversible cellular injury and death, followed by tissue autolysis and putrefaction.
Dry gangrene pathophysiology
Dry gangrene results from gradual arterial occlusion, typically in limbs with good venous drainage. Progressive ischemia depletes cellular ATP, causing failure of ion pumps and cellular swelling. When oxygen delivery cannot meet minimal metabolic demands, coagulative necrosis occurs. The tissue desiccates because venous and lymphatic drainage remain intact initially, removing fluid from the necrotic area. Bacterial growth is limited by low tissue moisture and oxygen levels. A clear demarcation line forms at the junction between viable and nonviable tissue as the body walls off the necrotic area through inflammatory response.
Wet gangrene pathophysiology
Wet gangrene develops when bacterial infection complicates ischemic tissue, or when venous/lymphatic obstruction prevents tissue drainage. Bacterial enzymes cause liquefactive necrosis with tissue breakdown into liquid, malodorous material. Edema from venous congestion creates an ideal anaerobic environment for bacterial proliferation. Bacteria produce toxins and enzymes (collagenases, hyaluronidases) that destroy tissue architecture and facilitate spread. The infected tissue cannot mount effective immune response due to impaired blood supply. Bacterial endotoxins and inflammatory mediators enter systemic circulation, causing sepsis.
Gas gangrene pathophysiology
Clostridium perfringens and related species produce powerful exotoxins (alpha toxin/phospholipase C) that destroy cell membranes and cause massive hemolysis. Bacterial fermentation of tissue glucose produces hydrogen and carbon dioxide gas, creating characteristic crepitus and visible gas in tissue planes on imaging. Myonecrosis progresses rapidly (inches per hour) as toxins spread through fascial planes. Alpha toxin also causes platelet aggregation and microvascular thrombosis, extending the zone of ischemia.
Clinical features
Clinical presentation varies by gangrene type, but early recognition is critical for limb and life salvage.
Dry gangrene
Symptoms:
- Severe pain in affected limb (initially), becoming painless as nerves die
- Coldness and numbness in extremity
- Progressive color changes: pallor → cyanosis → black
Signs:
- Clear line of demarcation between viable and dead tissue
- Black, dry, mummified appearance of necrotic tissue
- Absence of edema or discharge
- Loss of pulses distal to occlusion
- Shriveled, hard consistency
- No systemic signs unless infection supervenes
Wet gangrene
Symptoms:
- Severe, constant pain
- Rapid onset and progression
- Fever, chills, malaise
- Confusion (in elderly)
Signs:
- Swollen, edematous tissue
- Skin blisters and bullae
- Brown-red to black discoloration
- Foul-smelling discharge or drainage
- Soft, boggy tissue consistency
- Crepitus may be present
- Systemic toxicity: tachycardia, hypotension, altered mental status
Gas gangrene
Symptoms:
- Sudden onset of severe pain disproportionate to physical findings
- Sense of heaviness in affected limb
- Rapid progression over hours
Signs:
- Tense, edematous extremity
- Bronze or brown skin discoloration
- Hemorrhagic bullae
- Crepitus on palpation (pathognomonic)
- Thin, watery, brown discharge ("dishwater" pus)
- Systemic toxicity and shock
- Tachycardia out of proportion to fever
Fournier gangrene
- Scrotal, perineal, or penile pain and swelling
- Erythema progressing to dusky discoloration
- Crepitus in perineal tissues
- Systemic sepsis
Diagnosis
Diagnosis of gangrene is primarily clinical, supported by imaging and laboratory studies. Early diagnosis is essential as delayed treatment significantly increases morbidity and mortality.
Clinical assessment
- Complete physical examination including vascular assessment (pulses, ankle-brachial index)
- Inspection of all at-risk areas (feet, pressure points, perineum)
- Assessment for systemic signs of infection
- Evaluation of extent and depth of tissue involvement
Laboratory studies
Essential tests:
- Complete blood count: leukocytosis (often with left shift in wet/gas gangrene), anemia
- Basic metabolic panel: hyperkalemia, elevated creatinine (rhabdomyolysis)
- Creatine kinase: markedly elevated in gas gangrene with muscle involvement
- Blood cultures: positive in 60% of cases with wet gangrene
- Lactate: elevated in sepsis
- Coagulation studies: may show DIC in severe cases
Additional tests:
- Hemoglobin A1c: assess diabetic control
- Wound culture: identify causative organisms (aerobic and anaerobic)
- Gram stain: large gram-positive rods (Clostridium) in gas gangrene
Imaging
Plain radiography:
- Gas in soft tissues (radiolucent streaks along fascial planes)
- Useful for gas gangrene and some wet gangrene cases
- Should not delay surgical intervention
CT imaging:
- Defines extent of tissue involvement
- Identifies gas in fascial planes and muscle
- Assesses vascular anatomy
- Helpful for surgical planning
MRI:
- Superior soft tissue detail
- Distinguishes cellulitis from necrotizing infection
- Not practical in unstable patients
Vascular studies:
- Arterial Doppler ultrasound: assess arterial flow
- Ankle-brachial index (ABI): <0.4 indicates severe ischemia
- CT or conventional angiography: evaluate for revascularization options
Diagnostic criteria
Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score (useful for differentiating necrotizing from non-necrotizing infection):
- CRP >150 mg/L: 4 points
- WBC 15-25: 1 point; WBC >25: 2 points
- Hemoglobin 11-13.5 g/dL: 1 point; Hemoglobin <11 g/dL: 2 points
- Sodium <135 mmol/L: 2 points
- Creatinine >1.6 mg/dL: 2 points
- Glucose >180 mg/dL: 1 point
Score ≥6 suggests necrotizing infection (though clinical suspicion supersedes scoring).
Differential diagnosis
Several conditions may mimic gangrene or must be distinguished to guide appropriate management.
Vascular conditions:
- Acute limb ischemia: Painful, pale, pulseless, paresthetic limb without tissue necrosis yet
- Chronic critical limb ischemia: Rest pain and tissue loss without established gangrene
- Acrocyanosis: Persistent blue discoloration without necrosis, symmetrical, improves with warming
- Raynaud phenomenon: Episodic color changes (white-blue-red), reversible, no tissue loss
Infectious conditions:
- Cellulitis: Erythema and edema without crepitus or systemic toxicity
- Necrotizing fasciitis: Rapid progression, severe pain, may not have visible necrosis initially
- Pyomyositis: Muscle abscess without gas or extensive necrosis
- Septic arthritis: Joint involvement with effusion
Other necrotic conditions:
- Pressure ulcers: Localized tissue breakdown over bony prominence, clear pressure etiology
- Calciphylaxis: Painful skin necrosis in dialysis patients, often with livedo pattern
- Warfarin-induced skin necrosis: Early in warfarin therapy, affects breast/buttocks/thighs
- Pyoderma gangrenosum: Inflammatory ulceration, associated with IBD, begins as pustule
- Venous ulcers: Gaiter area distribution, surrounding hemosiderin deposition, minimal pain
Key distinguishing features:
| Feature | Dry gangrene | Wet gangrene | Gas gangrene |
|---|---|---|---|
| Onset | Gradual (days-weeks) | Rapid (hours-days) | Very rapid (hours) |
| Pain | Initially severe, then absent | Severe, constant | Severe, disproportionate |
| Tissue | Dry, mummified | Wet, edematous | Tense, edematous |
| Odor | Absent | Foul | Sweet or absent |
| Crepitus | Absent | Sometimes present | Always present |
| Systemic signs | Absent | Present | Severe |
| Demarcation | Clear | Indistinct | Indistinct |
Management
Management of gangrene requires prompt recognition, aggressive intervention, and multidisciplinary care. Treatment principles include controlling infection, removing dead tissue, restoring perfusion when possible, and preventing complications.
Emergency management (wet and gas gangrene)
Immediate resuscitation:
- Intravenous fluid resuscitation for hemodynamic support
- Broad-spectrum antibiotics within 1 hour of recognition
- ICU admission for monitoring and organ support
- Correction of metabolic abnormalities (hyperkalemia, acidosis)
Urgent surgical debridement:
- Emergency surgery is definitive treatment for wet and gas gangrene
- Remove all necrotic tissue until bleeding, viable tissue is reached
- Multiple debridements often required (second-look within 24-48 hours)
- Early amputation may be lifesaving in extensive involvement
- Fasciotomy if compartment syndrome present
Antibiotic therapy
Empiric regimens (adjust based on cultures):
Wet gangrene/polymicrobial:
- Piperacillin-tazobactam OR
- Carbapenem (imipenem, meropenem) OR
- Ceftriaxone PLUS metronidazole
- Add vancomycin if MRSA risk
Gas gangrene:
- Penicillin G PLUS clindamycin (clindamycin inhibits toxin production)
- Clindamycin alone is alternative in penicillin allergy
Duration: Continue until no further debridement needed, patient afebrile, and WBC normalizing (typically 7-14 days)
Surgical management
Dry gangrene:
- Allow autoamputation if demarcation clear and no infection
- Elective amputation for functional reasons or if healing delayed
- Revascularization if viable tissue remains proximal to gangrene
Wet gangrene:
- Emergency surgical debridement
- Remove all necrotic and infected tissue
- Leave wounds open for staged closure
- Amputation when infection extends beyond viable salvage level
Gas gangrene:
- Immediate extensive debridement (life over limb)
- Wide excision of affected muscle groups
- Remove all discolored muscle that does not bleed or contract
- Amputation often required
Fournier gangrene:
- Aggressive perineal debridement
- Orchiectomy rarely needed (testes have separate blood supply)
- Colostomy if rectal involvement
Revascularization
In patients with dry gangrene and viable tissue proximal to necrosis:
- Endovascular intervention: Angioplasty with or without stenting for focal lesions
- Bypass surgery: For extensive occlusive disease when anatomy suitable
- Revascularization improves healing after amputation and may allow lower-level amputation
Adjunctive therapies
Hyperbaric oxygen therapy:
- Recommended for gas gangrene (increases tissue oxygen, inhibits bacterial toxin production)
- May benefit necrotizing soft tissue infections
- Not a substitute for surgery and antibiotics
- Typically 2-3 atmospheres for 90-120 minutes, twice daily
Negative pressure wound therapy:
- After initial debridement to promote granulation
- Reduces edema and bacterial load
- Facilitates delayed closure or skin grafting
Wound care:
- Daily inspection and dressing changes
- Maintain moist wound environment
- Protect surrounding skin
- Nutritional support for healing
Supportive care
- Glycemic control in diabetics
- Smoking cessation
- Nutritional optimization (protein, vitamins C and A, zinc)
- Pain management
- DVT prophylaxis
- Physical and occupational therapy
- Psychological support and rehabilitation
Level of amputation
Determined by:
- Extent of infection and necrosis
- Vascular perfusion at potential amputation level
- Functional considerations (knee preservation when possible)
- Healing potential (transcutaneous oxygen pressure >30-40 mmHg ideal)
Common levels: toe, transmetatarsal, below-knee, above-knee
Complications and prognosis
Gangrene carries significant morbidity and mortality, with outcomes depending on gangrene type, extent, rapidity of treatment, and patient comorbidities.
Complications
Local complications:
- Extension of infection to deeper structures (osteomyelitis, septic arthritis)
- Conversion of dry to wet gangrene with bacterial superinfection
- Amputation and resultant disability
- Phantom limb pain
- Contractures and chronic pain
- Failure of amputation stump to heal requiring higher-level amputation
Systemic complications:
- Sepsis and septic shock
- Acute kidney injury (from rhabdomyolysis, sepsis, or contrast)
- Disseminated intravascular coagulation
- Acute respiratory distress syndrome
- Multi-organ failure
- Death
Metabolic complications:
- Hyperkalemia from tissue breakdown
- Metabolic acidosis
- Hypoalbuminemia
- Anemia
Prognosis
Mortality rates:
- Dry gangrene: 5-10%
- Wet gangrene: 20-40%
- Gas gangrene: 25-40% (up to 100% if untreated)
- Fournier gangrene: 20-40%
Factors predicting worse outcome:
- Delayed presentation (>24 hours from symptom onset)
- Extensive involvement
- Advanced age (>70 years)
- Shock at presentation
- Renal failure
- Immunosuppression
- Multiple comorbidities
Functional outcomes:
Following lower extremity amputation:
- Below-knee amputation: 80-90% ambulate with prosthesis
- Above-knee amputation: 40-60% ambulate with prosthesis
- Bilateral amputation significantly reduces ambulation rates
- 5-year mortality after major amputation: 40-70% (primarily from cardiovascular disease)
- Contralateral limb amputation risk: 10-20% at 3 years
Recurrence:
In patients with peripheral arterial disease or diabetes who survive initial gangrene:
- 5-10% require contralateral amputation within 1 year
- 30% require additional ipsilateral procedures
- Risk reduction through smoking cessation, glycemic control, regular foot care, and vascular surveillance
Quality of life:
Amputees experience reduced quality of life related to:
- Loss of mobility and independence
- Chronic pain
- Depression and anxiety
- Social isolation
- Employment difficulties
Multidisciplinary rehabilitation including prosthetics, physical therapy, and psychological support improves outcomes.
GANGRENE risk factors: Glycemic dyscontrol (diabetes), Atherosclerosis/arterial disease, Neuropathy, Gas-producing organisms (Clostridium), Raynaud/vasculitis, Embolism, Necrosis/trauma, Elderly age
Practice questions
1. A 68-year-old man with type 2 diabetes and a 40-pack-year smoking history presents with a 3-week history of progressive blackening of his right great toe. He reports the toe was initially very painful but is now numb. On examination, the toe is black, dry, and mummified with a clear line of demarcation at the metatarsophalangeal joint. The toe is pulseless, and posterior tibial and dorsalis pedis pulses are diminished. Temperature is 37.1°C (98.8°F), blood pressure is 145/85 mmHg, and heart rate is 78/min. The patient is not in distress. What is the most appropriate next step in management?
2. A 45-year-old man presents to the emergency department with severe right thigh pain that began 6 hours ago after a minor penetrating injury while working on a farm. On examination, his temperature is 38.9°C (102°F), blood pressure is 90/60 mmHg, and heart rate is 125/min. The right thigh is tense, swollen, and has bronze discoloration with multiple hemorrhagic bullae. Crepitus is palpable on examination. Thin, brown watery discharge is draining from the wound. Laboratory studies show WBC 24,000/mm³, creatine kinase 15,000 U/L, and creatinine 2.1 mg/dL. Which organism is most likely responsible?
3. A 72-year-old woman with poorly controlled diabetes presents with a 2-day history of foul-smelling discharge and fever from a chronic foot ulcer. Temperature is 39.2°C (102.6°F), blood pressure is 85/50 mmHg, and heart rate is 118/min. The lateral aspect of the foot is swollen, erythematous, and has areas of black, wet necrosis with purulent drainage. The patient appears confused. Laboratory studies show WBC 22,000/mm³ with 15% bands, glucose 420 mg/dL, creatinine 2.5 mg/dL, and lactate 4.2 mmol/L. Blood cultures are pending. After initiating fluid resuscitation, what is the most appropriate next step in management?
Frequently asked questions
What causes gangrene?
Gangrene is caused by loss of blood supply to tissue (ischemia) or bacterial infection. The most common causes are peripheral arterial disease from atherosclerosis and diabetes mellitus. Other causes include blood clots, severe trauma, frostbite, burns, and infections with bacteria like Clostridium perfringens. Smoking, advanced age, immunosuppression, and chronic kidney disease increase risk. Dry gangrene results from gradual arterial blockage without infection, while wet gangrene occurs when bacteria invade ischemic tissue. Gas gangrene is caused by Clostridium bacteria releasing toxins and gas into tissues.
What are the first symptoms of gangrene?
Early symptoms depend on gangrene type. Dry gangrene begins with severe pain in the affected limb, coldness, numbness, and progressive color changes from pale to blue to black. As nerves die, pain may disappear. Wet gangrene causes sudden severe pain, swelling, skin discoloration, fever, and foul-smelling discharge. Gas gangrene produces intense pain disproportionate to visible findings, rapid swelling, and a feeling of heaviness in the limb. All types may show loss of pulses and cold skin. Wet and gas gangrene progress rapidly over hours and cause systemic illness including confusion, rapid heart rate, and shock.
How is gangrene diagnosed?
Gangrene is diagnosed primarily by clinical examination showing dead, discolored tissue (black, brown, or dusky), often with clear demarcation from healthy tissue. The doctor assesses pulses, skin temperature, and sensation. Laboratory tests show elevated white blood cells, elevated creatine kinase in gas gangrene, and positive blood cultures in infected cases. X-rays or CT scans reveal gas in tissues (radiolucent streaks) in gas gangrene. Vascular studies including Doppler ultrasound and ankle-brachial index assess blood flow. Wound cultures identify causative bacteria. MRI can define extent but should not delay treatment in unstable patients.
Is gangrene curable?
Gangrene itself is not reversible, as the tissue is already dead, but treatment can stop progression and save the limb or life. Dry gangrene may heal through autoamputation where dead tissue falls off, or may require surgical removal. Wet gangrene and gas gangrene require emergency surgery to remove all dead and infected tissue, combined with intravenous antibiotics. Revascularization procedures can restore blood flow to remaining viable tissue. Amputation is sometimes necessary when infection is extensive. With prompt treatment, survival rates are good, but delays significantly increase mortality. Prevention through managing diabetes and vascular disease is key.
Dry gangrene vs wet gangrene — what is the difference?
Dry gangrene is tissue death from blocked blood supply without bacterial infection, while wet gangrene involves bacterial invasion of dead tissue. Dry gangrene develops gradually, appears black and mummified, has clear borders, no odor, and no systemic illness. Wet gangrene progresses rapidly, appears swollen and brown-red, has foul-smelling discharge, causes fever and shock, and can be fatal within days. Dry gangrene can be managed conservatively or with elective surgery, but wet gangrene is a surgical emergency requiring immediate debridement and antibiotics. Dry gangrene can convert to wet gangrene if bacteria enter the dead tissue.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: I70.2
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.